Treatment of immune-mediated keratitis in horses with episcleral silicone matrix cyclosporine delivery devices.

about

Suspected malignant transformation of B lymphocytes in the equine cornea from immune-mediated keratitis.Use of episcleral cyclosporine implants in dogs with keratoconjunctivitis sicca: pilot study.

P2860

Q39013473-E9DD66D0-4D6D-4C2C-8E6D-1698629C7537 Q53558849-990AA141-0DEB-4468-B5D2-66957DFF0452

P2860

Treatment of immune-mediated keratitis in horses with episcleral silicone matrix cyclosporine delivery devices.

Item

http://www.wikidata.org/entity/Q44869053

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Treatment of immune-mediated k ...... cyclosporine delivery devices.

@en

Treatment of immune-mediated k ...... cyclosporine delivery devices.

@nl

type

Item

label

Treatment of immune-mediated k ...... cyclosporine delivery devices.

@en

Treatment of immune-mediated k ...... cyclosporine delivery devices.

@nl

prefLabel

Treatment of immune-mediated k ...... cyclosporine delivery devices.

@en

Treatment of immune-mediated k ...... cyclosporine delivery devices.

@nl

P1476

Treatment of immune-mediated k ...... cyclosporine delivery devices

@en

P2093

Alison B Clode

http://www.w3.org/2001/XMLSchema#string

David A Wilkie

http://www.w3.org/2001/XMLSchema#string

Jacklyn H Salmon

http://www.w3.org/2001/XMLSchema#string

Joseph Gerding

http://www.w3.org/2001/XMLSchema#string

Julie Hempstead

http://www.w3.org/2001/XMLSchema#string

Nelson H Pinto

http://www.w3.org/2001/XMLSchema#string

Riccardo Stoppini

http://www.w3.org/2001/XMLSchema#string

P2860

Assessing a novel depot delivery strategy for noninvasive administration of VEGF/PDGF RTK inhibitors for ocular neovascular disease.

Equine immune-mediated keratopathies.

The use of amniotic membrane transplantation for ocular surface reconstruction: a review and series of 58 equine clinical cases (2002-2008).

Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis.

Ocular parameters related to drug delivery in the canine and equine eye: aqueous and vitreous humor volume and scleral surface area and thickness.

Distribution of cyclosporin A in the cornea after topical or oral administration.

A novel bioerodible deep scleral lamellar cyclosporine implant for uveitis.

Immune-mediated keratitis in horses: 19 cases (1998-2004).

Immunohistochemical and immunopathologic characterization of superficial stromal immune-mediated keratitis in horses.

Sustained release cyclosporine therapy for bilateral keratoconjunctivitis sicca in a red wolf (Canis rufus).

P304

23-30

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/VOP.12087

http://www.w3.org/2001/XMLSchema#string

P478

17 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

Brian C. Gilger

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255175430

http://www.w3.org/2001/XMLSchema#string

P698

23910236

http://www.w3.org/2001/XMLSchema#string

Treatment of immune-mediated keratitis in horses with episcleral silicone matrix cyclosporine delivery devices.

about

P2860

P2860

Treatment of immune-mediated keratitis in horses with episcleral silicone matrix cyclosporine delivery devices.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698